Catalyst overview
Research summary
This catalyst tracks a Phase 3 update for Dysport/AbobotulinumtoxinA (Botulinum Neurotoxin) in Migraine Prevention. The expected timing is based on the latest available company guidance and may change.
07/30/26:- BEOND Ph3 migraine data positive; regulatory submissions and future congress presentation planned.
Verification
Confirm timing and program details against the company announcement or filing.